TY - JOUR
T1 - The influence of Helicobacter pylori on the ethnic distribution of Barrett's metaplasia
AU - Sonnenberg, A.
AU - Turner, K. O.
AU - Spechler, S. J.
AU - Genta, R. M.
N1 - Publisher Copyright:
© 2016 John Wiley & Sons Ltd
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Background: Environmental risk factors associated with ethnicity may contribute to the occurrence of Barrett's metaplasia. Aim: To investigate the interaction between ethnicity and Helicobacter pylori infection in the occurrence of Barrett's metaplasia among patients undergoing oesophago-gastro-duodenoscopy. Methods: The Miraca Life Sciences Database is an electronic repository of histopathological patient records. A case–control study evaluated the influence of age, gender, ethnicity and histological diagnosis of H. pylori on the occurrence of Barrett's metaplasia. Results: The total study population comprised 596 479 subjects, of whom 76 475 harboured a diagnosis of Barrett's metaplasia. Male sex, age and H. pylori infection in declining order exerted the strongest influence on the occurrence of BM. In comparison with the population comprising Caucasians and African Americans, Barrett's metaplasia was less common among subjects of African (OR = 0.09, 95% CI = 0.01–0.43), Middle Eastern (0.26, 0.20–0.34), East Asian (0.35, 0.31–0.40), Indian (0.39, 0.32–0.47), Hispanic (0.62, 0.59–0.64) or Jewish descent (0.50, 0.45–0.54), but more common among subjects of Northern European descent (1.14, 1.03–1.26). With the exception of Jews and Northern Europeans, all other ethnic subgroups were characterised by a higher prevalence of H. pylori than the comparison group. A low prevalence of H. pylori was significantly associated with a high prevalence of Barrett's metaplasia (R2 = 0.82, P < 0.001), as well as dysplasia or oesophageal adenocarcinoma (R2 = 0.81, P < 0.001). Conclusion: Our analysis reveals an inverse relationship between the prevalence of Barrett's metaplasia and H. pylori gastritis among different ethnic groups within the United States.
AB - Background: Environmental risk factors associated with ethnicity may contribute to the occurrence of Barrett's metaplasia. Aim: To investigate the interaction between ethnicity and Helicobacter pylori infection in the occurrence of Barrett's metaplasia among patients undergoing oesophago-gastro-duodenoscopy. Methods: The Miraca Life Sciences Database is an electronic repository of histopathological patient records. A case–control study evaluated the influence of age, gender, ethnicity and histological diagnosis of H. pylori on the occurrence of Barrett's metaplasia. Results: The total study population comprised 596 479 subjects, of whom 76 475 harboured a diagnosis of Barrett's metaplasia. Male sex, age and H. pylori infection in declining order exerted the strongest influence on the occurrence of BM. In comparison with the population comprising Caucasians and African Americans, Barrett's metaplasia was less common among subjects of African (OR = 0.09, 95% CI = 0.01–0.43), Middle Eastern (0.26, 0.20–0.34), East Asian (0.35, 0.31–0.40), Indian (0.39, 0.32–0.47), Hispanic (0.62, 0.59–0.64) or Jewish descent (0.50, 0.45–0.54), but more common among subjects of Northern European descent (1.14, 1.03–1.26). With the exception of Jews and Northern Europeans, all other ethnic subgroups were characterised by a higher prevalence of H. pylori than the comparison group. A low prevalence of H. pylori was significantly associated with a high prevalence of Barrett's metaplasia (R2 = 0.82, P < 0.001), as well as dysplasia or oesophageal adenocarcinoma (R2 = 0.81, P < 0.001). Conclusion: Our analysis reveals an inverse relationship between the prevalence of Barrett's metaplasia and H. pylori gastritis among different ethnic groups within the United States.
UR - http://www.scopus.com/inward/record.url?scp=85002045010&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85002045010&partnerID=8YFLogxK
U2 - 10.1111/apt.13854
DO - 10.1111/apt.13854
M3 - Article
C2 - 27862104
AN - SCOPUS:85002045010
SN - 0269-2813
VL - 45
SP - 283
EP - 290
JO - Alimentary Pharmacology and Therapeutics
JF - Alimentary Pharmacology and Therapeutics
IS - 2
ER -